Gaurav Chandra
Director/Board Member bei ENZOLYTICS, INC.
Aktive Positionen von Gaurav Chandra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENZOLYTICS, INC. | Director/Board Member | - | - |
Chief Operating Officer | 01.12.2020 | 19.03.2024 | |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Chief Operating Officer | - | - |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Chief Executive Officer | - | - |
Karriereverlauf von Gaurav Chandra
Ausbildung von Gaurav Chandra
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Kasturba Medical College | Undergraduate Degree |
University of Colorado Denver | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Indien | 2 |
Operativ
Chief Operating Officer | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ENZOLYTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Health Technology |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Commercial Services |
- Börse
- Insiders
- Gaurav Chandra
- Erfahrung